• Corpus ID: 7432975

Molecular Characterization of the Vasculature of Patients with Infiltrating Ductal Carcinoma Generates a Gene Signature Predictive of Breast Cancer Survival

  title={Molecular Characterization of the Vasculature of Patients with Infiltrating Ductal Carcinoma Generates a Gene Signature Predictive of Breast Cancer Survival},
  author={Phuong Uyen Le and J. Li and Christiane Cantin and Catherine Collins and Andr{\'e} Nantel and Tammy‐Lynn Tremblay and John F Kelly and Edwin Wang and Maureen D. O’Connor-McCourt and Anne E. G. Lenferink},
Targeting of the tumor vasculature has evolved into an integral part of existing standard anti-cancer therapies. However, recent pre-clinical and clinical studies have shown that the efficacy of these treatments is often temporary and frequently followed by renewed tumor growth. In an attempt to overcome this problem we transcriptionally profiled laser capture micro dissected micro vessels from both tumor and matching adjacent normal breast tissue obtained from patients diagnosed with… 
1 Citations

Figures from this paper

Meta-Analysis of Microdissected Breast Tumors Reveals Genes Regulated in the Stroma but Hidden in Bulk Analysis

This work aimed at creating a comprehensive resource of transcriptomic datasets investigating breast cancers, focusing on microdissected tumors, which enable the distinguishing of the contribution of the tumor microenvironment from that of cancer cells.



Molecular characterization of human breast tumor vascular cells.

Fibroblast activation protein, secreted frizzled-related protein 2, Janus kinase 3, and neutral sphingomyelinase 2 proteins localized to breast tumor endothelium as assessed by immunohistochemistry, showing significantly greater staining compared with normal tissue, may serve as potential targets for the development of angiogenesis inhibitors.

Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypes

A deeper molecular understanding of the heterogeneity existing within the breast tumor vasculature is provided and opens new avenues toward the improved design and targeting of antiangiogenic therapies.

Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry.

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.

It is shown that both overall survival and distant metastasis-free survival are markedly diminished in patients whose tumors expressed this wound-response signature compared to tumors that did not express this signature.

Gene expression profiling predicts clinical outcome of breast cancer

DNA microarray analysis on primary breast tumours of 117 young patients is used and supervised classification is applied to identify a gene expression signature strongly predictive of a short interval to distant metastases (‘poor prognosis’ signature) in patients without tumour cells in local lymph nodes at diagnosis, providing a strategy to select patients who would benefit from adjuvant therapy.

Alterations in Vascular Gene Expression in Invasive Breast Carcinoma

The expression of HEyl in tumor endothelial cells is demonstrated and the ability of HEYL to both induce proliferation and attenuate programmed cell death of primary endothelial Cells in vitro is established.

Development and characterization of a novel method for the analysis of gene expression patterns in lymphatic endothelial cells derived from primary breast tissues

Results indicate that the combination of RIHC–LCM, two-round linear amplification of the small sample RNA and genome-wide microarray analysis allows gene expression profiling of tumor LECs, which provides a powerful tool for the study of molecular details in human lymphangiogenesis-related diseases, such as lymphatic metastasis of human breast cancers.

Repeated observation of breast tumor subtypes in independent gene expression data sets

The results strongly support the idea that many of these breast tumor subtypes represent biologically distinct disease entities.

A positive relationship between filamin and VEGF in patients with lung cancer.

Although the findings do not suggest that the expression of FLNA alone plays an independent prognostic role, the angiogenesis pathway mediated by FLNA appears to be responsible for controlling the growth of lung tumors.

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

The recurrence score has been validated as quantifying the likelihood of distant recurrence in tamoxifen-treated patients with node-negative, estrogen-receptor-positive breast cancer and could be used as a continuous function to predict distant recurrent in individual patients.